Health

Toxic Metals in Baby Food Remain Unregulated

Toxic Metals in Baby Food Remain Unregulated

Despite delayed government action, manufacturers can do more to reduce toxic metals in baby food.

Telehealth Abortion Care

Telehealth Abortion Care

Scholars consider how the authorization of telehealth can expand access to medication abortion.

Are Food Regulators Stepping up to the Plate?

Are Food Regulators Stepping up to the Plate?

In this week’s Saturday Seminar, we collect scholarship discussing quality and safety issues within U.S. food regulation.

Hallucinate, Medicate, and Regulate

Hallucinate, Medicate, and Regulate

In this week’s Saturday Seminar, experts discuss ways to regulate psychedelics for medicinal use.

Nonprofit Hospital Standards Under Fire

Nonprofit Hospital Standards Under Fire

Research shows that nonprofit hospitals may not be fulfilling the obligations of their tax-exempt status

Using Insurance to Regulate Food Safety

Using Insurance to Regulate Food Safety

Insurance underwriters can help farmers manage the risk of microbial contamination in their fields.

Reforming Accountable Care Organizations

Reforming Accountable Care Organizations

Experts explore opportunities to reduce costs and promote health equity.

Cancer Moonshot Lands with FDA

Cancer Moonshot Lands with FDA

FDA releases new guidelines for cancer clinical trials in response to President Biden’s anti-cancer initiative.

With Proposed Menthol Cigarette Rule, FDA Says Cool It

With Proposed Menthol Cigarette Rule, FDA Says Cool It

FDA issues proposed rule that would ban menthol as a flavor additive in cigarettes.

The No Surprises Act Still Surprises Consumers

The No Surprises Act Still Surprises Consumers

Medical bills may continue to take consumers by surprise despite the No Surprises Act.

A Review of Health Care in the Court

A Review of Health Care in the Court

Several U.S. Supreme Court cases from this past term have significant implications for the provision of medical care.

Emergency Use or Overuse?

Emergency Use or Overuse?

Experts discuss FDA’s COVID-19 emergency authorizations and how to recalibrate the regulatory mechanism.